KRISTEN HALL: Open Payments
NPI 1346449550 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,104 in 90 payments from 24 companies in 2025. Trend: 2023 $1,382 · 2024 $1,182 · 2025 $2,104
Food & beverage: $2,086Education: $17
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $336 |
| GlaxoSmithKline, LLC. | 13 | $276 |
| AstraZeneca Pharmaceuticals LP | 10 | $221 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $190 |
| GENZYME CORPORATION | 7 | $162 |
| Verona Pharma, Inc. | 12 | $161 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $132 |
| Insmed, Inc. | 4 | $80 |
| Electromed, Inc. | 7 | $63 |
| Viatris Specialty LLC | 3 | $58 |
Products named: DUPIXENT, NUCALA, Ohtuvayre, LUMRYZ, GLASSIA, HYQVIA, FASENRA, TEZSPIRE.
Industry payments across SC — which companies pay providers there.
